Salvage radiation decision: with or without hormone therapy?
I had a prostatectomy in 2021. PSA was undetectable for 2 years. Then PSA went to 0.1 in 2023, and then 0.2 in 2024. I saw an Oncologist last month who recommends salvage radiation to the prostate bed. I will do that soon, but first need to make a decision on whether I should do hormone therapy with the radiation therapy. I have a family history of prostate cancer, and my PSA was fairly low (5.0) when I had the initial biopsy and diagnosis, which showed prostate cancer existed in all samples. The Gleason score was the bad 7. I had a PET scan and bone scan before surgery which did not show any signs of metastatic prostate cancer. So my question to the group is: should I do hormone therapy at this time? Or just do radiation and see if that works? I'm 64 and in good health.
Interested in more discussions like this? Go to the Prostate Cancer Support Group.
That is AWESOME news!!! Love the PSA. I've had a very similar path. My Gleason was 8-9. Had surgery to remove the prostate. All 11 lymph nodes clear. First PSA was .2 so so obviously some cells still there. PSA then rose to .8 after 6 months so radiation and ADT was the plan of attack. Eight months after, my PSA is at .01.
My question, was does the a positive lymph node mean going forward? Really new here. Thanks everyone!!!
@jaacm1 You mentioned you have manageable incontinence and ED. I also have these issues following RP surgery and I never fully recovered. As I'm considering ADT, I've read that it could have significant side effects regarding incontinence and ED. Was your incontinence and ED a result of your RP surgery, or did it happen after starting Orgovyx? If it was a result of RP, did it get worse after starting Orgovyx?
Chuck, I was able to overcome my incontinence after RP by doing kegels. Regarding ED, I was ok (needed a prescription) after RP but not 100% the same as I was heading into the procedure. Orgovyx worked well on me and lowered my T from over 600 to almost nothing. For the 6 months I was on the drug it eliminated all interest/ desire. When I came off the Orgovyx and had gone through SRT, the desire returned but I still need a pill. That said, the combo of the hormone and the SRT definitely negatively impacted me as compared to where I was pre-RP and post RP. My T is over 500 last time it was checked.
ADT reduces testosterone levels, and androgens play a role in maintaining the strength of pelvic floor muscles. When these muscles weaken due to ADT, it can lead to urinary incontinence.
The ED problems occur after surgery, The ADT drugs take away the desire, Which can’t affect the ability to get an erection, But the real problem is that many men after RP just can’t get it up without assistance from drugs or a pump.
Jeff - thanks for all the information you have been providing on the questions I've been asking. You are very knowledgeable about the current research and treatment options. After reading the messages from you and others, it seems like ADT slows down cancer growth, but doesn't kill the cancer cells. And the only way to actually kill the cancer cells is through surgery or radiation. Also the cancer cells can mutate to make them ADT resistant. So it seems there is a high probability after ADT treatment that the cancer will eventually come back, and could become castration resistant.
I'm 64 and currently have a PSA of 0.2 after 4 years post RP, PSADT of 1 year, post RP clean margins and lymph nodes, and a negative PSMA/PET scan. I didn't have a decipher test done at the time of RP surgery. In a Dr. Kwon video, his recommendation was to wait until a scan positively identifies the cancer spot and then kill it with radiation. I'm hoping to get into Mayo soon to have a Choline 11 scan done. If that is also negative, does the current body of research support waiting until a scan identifies the cancer? Are there stats showing the effectiveness of waiting to identify the cancer and using radiation to kill it? For example, after this treatment plan, how many patients have their PSA increase again and have additional radiation treatments?
I believe I saw a statistic that salvage radiation to the prostate bed is about 30% effective at killing all remaining cancer cells with a PSA around 0.2 - is that correct? Are there stats showing how much more effective adding the ADT therapy on top of the radiation is?
Lots to consider and I appreciate your help and everyone else who is contributing to this forum! I will continue to share my treatment plan and effectiveness as well. A Huge Thank You To Everyone!!
You have had a lot of important points, Chuck. With your low PSA it sure seems you should wait until you have a fast Doubling time, and your PSA is higher, before you start worrying about the options below. You are at .2, How fast did it get there?
Here are Some things that relate to having Reoccurrence with or without metastasis
At the recent PCRI conference it was mentioned that only 1/3 of the people that get salvage radiation benefit from it, In that they have no further remission.
Both Dr. Kwon and Dr. Scholz Are real enthusiasts about using SBRT to just zap the metastasis and you can go home happy and not worrying about it.
These two things sort of collide together. Currently the SBRT scan cannot see metastasis smaller than 2.7 mm and in some case even at 5 mm It can’t always be determined (from recent UCSF conference).
That means you could be waiting for metastasis to show up while many other mini metastasis are growing. Because the prostate is removed the area around there is the most likely place that something could have microscopically spilled and be spreading. As was mentioned in the PCRI conference “Seeds for metastasis were already there when surgery was done, waiting to grow.” That’s where salvage radiation becomes to make some sense.
It could be the C11 scan can detect smaller Metastasis.
Dr. Scholz was real emphatic, At the PCRI conference, about using the SBRT technique to keep his patients in remission.
So now you have a little bit of both sides of that story.
As for adding ADT if you’ve had a metastasis or remission, ADT is normally the recommended treatment. Even an ARSI may be used at the same time if the cancer looks like it could be aggressive.
Here is a treatment guide I got from one of the Conferences.. Anti—hormones is referring to drugs like ADT.
The SPPORT trial may provide some information relevant to your inquiries.
My understanding is post RP PSA of .2 - .4/.5 is the "sweet spot" for Salvage Treatment.
Post RP my 1st PSA was .19 (persistent) and the treatment at Johns Hopkins was Salvage Radiation to the whole prostate region together with the pelvic lymph nodes together with short term ADT.
2 PSMA Pet scans, 1 preop and 1 post-op did not identify specific areas of recurrence.
2 friends with 2 different ROs at JH received similar treatment.
All 3 of us have had undetectable PSAs for about 2 yrs now since completing salvage treatment.
Personally, I would take the negative PSMA PET together with the relatively low PSA as an opportunity to treat the recurrence at an early opportunity. Layman understanding and experience.
Best wishes.
There is a study published by Dana Farber about the timing of salvage radiation. A simple Google search should find it. It suggests that starting SRT prior a recurrent PSA after RP reaching .25, in certain circumstances, can lead to better results.
Hi DP - your Lymph nodes were negative , right ? Gleason getting up there , BUT it appears the EBRT did its job . How long have you been off ADT . Your PSA is great now at 0.01 . You may have ADT in your system though(?) . Plenty of guys get EBRT after surgery ( 2 year mark is common) Some with ADT , some not . I think most Dr's see what your stat is before using ADT . Gob Bless and let us know .
Here is that info
From Ascopubs about what PSA to do salvage radiation.
≤0.2 ng/mL: Starting at this level maximizes disease control and long-term survival. Patients treated at PSA < 0.2 ng/mL achieve higher rates of undetectable post-SRT PSA (56-70%) and improved 5-year progression-free survival (62.7-75%). Delaying SRT beyond PSA ≥0.25 ng/mL increases mortality risk by ~50%.
0.2–0.5 ng/mL: Still effective, particularly for patients with low-risk features (e.g., Gleason ≤7, slow PSA doubling time). The Journal of Clinical Oncology recommends SRT before PSA exceeds 0.25 ng/mL to preserve curative potential.
0.5–1.0 ng/mL: Salvage radiation remains beneficial but may require combining with androgen deprivation therapy (ADT) for higher-risk cases.